Publications by authors named "Anna Lugner"

Claim this Profile
A
An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health.
Anna K Lugnér, Paul F M Krabbe

Expert Rev Pharmacoecon Outcomes Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of restricted STI testing for young heterosexuals in the Netherlands on test costs and QALY losses.
Anita W M Suijkerbuijk, Eelco A B Over, Fleur van Aar, Hannelore M Götz, Birgit H B van Benthem

Health Policy· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of Lyme borreliosis.
Cees C van den Wijngaard, Agnetha Hofhuis, Albert Wong, Margriet G Harms, G Ardine de Wit

Eur J Public Health· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases.
Anita W M Suijkerbuijk, Robine Donken, Anna K Lugnér, G Ardine de Wit, Chris J L M Meijer

Expert Rev Vaccines· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.
Maria Xiridou, Anna Lugnér, Henry J C de Vries, Jan E A M van Bergen, Hannelore M Götz

Sex Transm Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of Lyme borreliosis expressed in disability-adjusted life years.
Cees C van den Wijngaard, Agnetha Hofhuis, Margriet G Harms, Juanita A Haagsma, Albert Wong

Eur J Public Health· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Costs of Measles Outbreak in the Netherlands, 2013-2014.
Anita W M Suijkerbuijk, Tom Woudenberg, Susan J M Hahné, Laura Nic Lochlainn, Hester E de Melker

Emerg Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
Alies van Lier, Anna Lugnér, Wim Opstelten, Petra Jochemsen, Jacco Wallinga

EBioMedicine· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal and respiratory illness in children that do and do not attend child day care centers: a cost-of-illness study.
Remko Enserink, Anna Lugnér, Anita Suijkerbuijk, Patricia Bruijning-Verhagen, Henriette A Smit

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[More efficient testing policy at STI clinics].
Anita W M Suijkerbuijk, Eelco A B Over, Femke D H Koedijk, Birgit H B van Benthem, Marianne A B van der Sande

Ned Tijdschr Geneeskd· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies.
Anna K Lugnér, Nicoline van der Maas, Michiel van Boven, Frits R Mooi, Hester E de Melker

Vaccine· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men.
Maria Xiridou, Henrike J Vriend, Anna K Lugner, Jacco Wallinga, Johannes S Fennema

BMC Infect Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective.
Henrike J Vriend, Anna K Lugnér, Maria Xiridou, Maarten F Schim van der Loeff, Maria Prins

AIDS· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
Anna K Lugnér, Michiel van Boven, Robin de Vries, Maarten J Postma, Jacco Wallinga

BMJ· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Swedish child-friendly pilot version of the EQ-5D instrument--the development process.
Kristina Burström, Ann-Charlotte Egmar, Anna Lugnér, Margareta Eriksson, Magnus Svartengren

Eur J Public Health· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investment in antiviral drugs: a real options approach.
Arthur E Attema, Anna K Lugnér, Talitha L Feenstra

Health Econ· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.
Anna K Lugnér, Sido D Mylius, Jacco Wallinga

Health Econ· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of pandemic influenza: review of cost-effectiveness studies.
Anna K Lugnér, Maarten J Postma

Expert Rev Pharmacoecon Outcomes Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
Anna K Lugnér, Maarten J Postma

Eur J Public Health· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
Hester Korthals Altes, Frederika Dijkstra, Anna Lugnèr, Frank Cobelens, Jacco Wallinga

Epidemiology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
Sabine C de Greeff, Anna K Lugnér, Danielle M van den Heuvel, Frits R Mooi, Hester E de Melker

Vaccine· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
Sido D Mylius, Thomas J Hagenaars, Anna K Lugnér, Jacco Wallinga

Vaccine· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis